Description
SomniTR is a delayed-release formula designed to initially release 1 mg of melatonin immediately after ingestion and 1 mg three hours later to help the patient stay asleep longer.*
SomniTR™ supports optimal melatonin production by supplementing multiple steps in the serotonin-to-melatonin pathway and also influences inhibitory GABAergic activity.*
A deficiency in melatonin levels can contribute to prolonged sleep latency, inability to stay asleep, disruption to circadian rhythms and jet lag.1 Disordered circadian rhythm is hypothesized to contribute to increased appetite and weight gain.2 Melatonin also has the capability to reduce ACTH-stimulated cortisol production that has been found to interrupt sleep.2
The delayed–release melatonin in SomniTR provides sustained levels for up to eight hours.
SomniTR also provides support for GABA-A receptor sites.* GABA-A agonists, such as Lactium have been shown to improve quality of sleep.*3 ForsLean supports cAMP4 while pantothenic acid supports acetyl coenzyme A,5 both of which are important in melatonin synthesis.*6
SomniTR provides support for patients with sleeping problems.* It may be taken in conjunction with Lentra™, Prolent™ and/or Tranquilent™.
Reviews
There are no reviews yet.